Ignite Creation Date:
2024-05-05 @ 6:41 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00524355
Status:
COMPLETED
Last Update Posted:
2009-07-17
First Post:
2007-08-30
Brief Title:
Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of the Gastroesophageal Reflux Disease
Status:
COMPLETED
Status Verified Date:
2009-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To describe the frequency type and severity of the symptoms in patients visiting the GI or internal physicians with symptoms consistent with gastroesophageal reflux disease GERD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NIS-G84-GER-20072 | None | None | None |